These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 16723889)

  • 1. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
    Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
    Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.
    Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G
    Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study.
    Majchrzak K; Kaspera W; Bobek-Billewicz B; Hebda A; Stasik-Pres G; Majchrzak H; Ładziński P
    Clin Neurol Neurosurg; 2012 Oct; 114(8):1135-44. PubMed ID: 22425370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
    Young R; Babb J; Law M; Pollack E; Johnson G
    J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.
    Jenkinson MD; Smith TS; Joyce KA; Fildes D; Broome J; du Plessis DG; Haylock B; Husband DJ; Warnke PC; Walker C
    Neuroradiology; 2006 Oct; 48(10):703-13. PubMed ID: 16937145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
    McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A
    Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
    Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
    Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient.
    Brasil Caseiras G; Ciccarelli O; Altmann DR; Benton CE; Tozer DJ; Tofts PS; Yousry TA; Rees J; Waldman AD; Jäger HR
    Radiology; 2009 Nov; 253(2):505-12. PubMed ID: 19789244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting.
    Caseiras GB; Chheang S; Babb J; Rees JH; Pecerrelli N; Tozer DJ; Benton C; Zagzag D; Johnson G; Waldman AD; Jäger HR; Law M
    Eur J Radiol; 2010 Feb; 73(2):215-20. PubMed ID: 19201123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.
    Smith JS; Chang EF; Lamborn KR; Chang SM; Prados MD; Cha S; Tihan T; Vandenberg S; McDermott MW; Berger MS
    J Clin Oncol; 2008 Mar; 26(8):1338-45. PubMed ID: 18323558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.
    Hakyemez B; Erdogan C; Bolca N; Yildirim N; Gokalp G; Parlak M
    J Magn Reson Imaging; 2006 Oct; 24(4):817-24. PubMed ID: 16958061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
    Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
    Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
    Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G
    J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional MR imaging with simultaneous measurements of cerebral blood volume and vascular permeability in ganglioglioma.
    Law M; Meltzer DE; Wetzel SG; Yang S; Knopp EA; Golfinos J; Johnson G
    Magn Reson Imaging; 2004 Jun; 22(5):599-606. PubMed ID: 15172052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early prognostic factors related to progression and malignant transformation of low-grade gliomas.
    Jung TY; Jung S; Moon JH; Kim IY; Moon KS; Jang WY
    Clin Neurol Neurosurg; 2011 Nov; 113(9):752-7. PubMed ID: 21889256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
    Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
    Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease?
    Bisdas S; Kirkpatrick M; Giglio P; Welsh C; Spampinato MV; Rumboldt Z
    AJNR Am J Neuroradiol; 2009 Apr; 30(4):681-8. PubMed ID: 19179427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
    Danchaivijitr N; Waldman AD; Tozer DJ; Benton CE; Brasil Caseiras G; Tofts PS; Rees JH; Jäger HR
    Radiology; 2008 Apr; 247(1):170-8. PubMed ID: 18372467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.